Randall Kaye

Insider Reports History

Location
San Diego, CA
Signature
/s/ Andrew J. Cronauer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Randall Kaye:

Company Role Class Num Shares Value Price $ Report Date Ownership
Longboard Pharmaceuticals, Inc. Executive Vice President & CMO Common Stock 0 $0 $60.00 02 Dec 2024 Direct
Longboard Pharmaceuticals, Inc. Executive Vice President & CMO Restricted Stock Unit 0 $0 $60.00 02 Dec 2024 Direct
Longboard Pharmaceuticals, Inc. Executive Vice President & CMO Stock Option (Right to Buy) 175,946 19 Nov 2024 Direct
Longboard Pharmaceuticals, Inc. Executive Vice President & CMO Retention Restricted Stock Units 9,500 25 Oct 2024 Direct
Longboard Pharmaceuticals, Inc. Executive Vice President & CMO Employee Stock Option (right to buy) 0 02 Dec 2024 Direct

Insider Reports Filed by Randall Kaye

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588924028023-kaye-randall-2024-12-02 Longboard Pharmaceuticals, Inc. 02 Dec 2024 6 -$1,833,240 4 Executive Vice President & CMO 02 Dec 2024, 19:21
/report/000095017024128962-kaye-randall-2024-11-19 Longboard Pharmaceuticals, Inc. 19 Nov 2024 2 +$183,324 4 CMO 19 Nov 2024, 20:13
/report/000095017024118315-kaye-randall-2024-10-25 Longboard Pharmaceuticals, Inc. 25 Oct 2024 1 $0 4 CMO 29 Oct 2024, 16:43
/report/000095017024115026-kaye-randall-2024-10-15 Longboard Pharmaceuticals, Inc. 15 Oct 2024 3 -$911,435 4 CMO 16 Oct 2024, 16:40
/report/000095017024106949-kaye-randall-2024-09-16 Longboard Pharmaceuticals, Inc. 16 Sep 2024 6 -$454,821 4 CMO 16 Sep 2024, 19:36
/report/000120919124003027-kaye-randall-2024-02-08 Longboard Pharmaceuticals, Inc. 08 Feb 2024 2 $0 4 CMO 09 Feb 2024, 16:11
/report/000095017024096496-kaye-randall-2024-01-23 Longboard Pharmaceuticals, Inc. 23 Jan 2024 6 -$505,908 4 CMO 13 Aug 2024, 18:01
/report/000120919123008399-kaye-randall-2023-02-09 Longboard Pharmaceuticals, Inc. 09 Feb 2023 1 $0 4 CMO 10 Feb 2023, 15:29
/report/000120919122020285-kaye-randall-2022-03-21 Longboard Pharmaceuticals, Inc. 21 Mar 2022 1 $0 4 CMO 21 Mar 2022, 17:18
/report/000120919122020284-kaye-randall-2022-03-21 Longboard Pharmaceuticals, Inc. 21 Mar 2022 0 $0 3 CMO 21 Mar 2022, 17:15